Reproductive technology allows us to test embryos' genes before deciding whether to transfer them to a woman's uterus. Embryo selection raises many ethical questions but is virtually unregulated in the United States. This comprehensive study considers the ethical, medical, political, and economic aspects of developing appropriate regulation.

Autorentext

Michelle Bayefsky is Pre-doctoral fellow in the Bioethics Department of the National Institutes of Health, USA. She has served as an intern at the Senate HELP Committee and UNESCO's Bioethics Programme, and a researcher at Yale's Interdisciplinary Center for Bioethics, USA. She graduated summa cum laude from Yale University, USA in 2014 with a B.A. in Ethics, Politics and Economics.

Bruce Jennings is Director of Bioethics at the Center for Humans and Nature and Senior Advisor at The Hastings Center, USA. He also holds faculty appointments at Vanderbilt University, USA and Yale University, USA. He has written widely on ethics and public policy issues, and is Editor-in-Chief of the influential reference work, Bioethics, 4th Edition (formerly the Encyclopedia of Bioethics), 6 vols. (2014).

Inhalt

1. Introduction 2. The Ethics of PGD and Its Relevance to Regulation 3. Drawing Ethical Lines 4. Regulating PGD in Practice 5. Paying for PGD 6. Conclusion